Key Takeaways
- A delegation of UK HealthTech innovators will visit Texas from March 3-7 as part of a trade initiative by the ABHI.
- The visit aims to facilitate networking with Texas healthcare leaders and organizations, enhancing UK HealthTech presence in the US market.
- The ABHI US Accelerator program supports UK companies entering the competitive US healthcare landscape.
UK HealthTech Delegation Visits Texas to Explore Opportunities
A delegation featuring over ten prominent UK HealthTech innovators, alongside Jay Mistry, Commercial Director of Oxford University Hospitals NHSFT, will visit Texas from March 3-7. The trip is organized by the Association of British HealthTech Industries (ABHI) as part of its US Accelerator program. The visit will encompass a series of meetings, networking events, and introductions across major Texas cities, including Austin, Dallas, and Houston, with the goal of showcasing the UK’s advanced health technology sector.
During this visit, representatives will meet with leadership teams from significant hospital systems such as Houston Methodist Hospital and Parkland Hospital, as well as engage decision-makers from insurance companies, investors, and procurement teams. A key highlight will be interactions with senior officials from the Texas Medical Center in Houston, the largest healthcare and life sciences complex globally, home to esteemed institutions like MD Anderson Cancer Center and Texas Children’s Hospital.
The delegation will actively participate in networking events and working groups, connecting with various supporting organizations such as the Dallas Chamber of Commerce and the Austin Healthcare Council. Paul Benton, Managing Director, International at ABHI, expressed enthusiasm about returning to Texas, emphasizing the unique access the delegation will have to senior leaders and the potential for establishing new trade partnerships in this vital market.
The ABHI US Accelerator program offers extensive support for UK HealthTech companies, leveraging partnerships with the Dell Medical School at the University of Texas in Austin and extensive networks across the US. Texas serves as a strategic entry point into other key markets. Notably, the state houses three of the top emerging life sciences clusters in the US—Houston, Austin, and Dallas-Fort Worth—alongside renowned research institutions.
The week-long mission will connect members of the ABHI US Accelerator with senior leaders and procurement teams from Texas’ leading hospital systems. A representative from Texas Health Resources highlighted the organization’s commitment to innovative healthcare solutions and the potential for continued collaboration with the UK health tech delegation in the future.
With over eight years of experience, the ABHI US Accelerator has assisted more than 100 UK HealthTech companies in entering the US market, facilitating their growth against competition. The program will welcome its 2025 cohort in April, starting with a two-day boot camp in London. This new group will explore key US healthcare destinations throughout the year, including areas like New Jersey and Arizona, alongside established spots like California and Florida.
For more information about joining the ABHI US Accelerator and exploring expansion opportunities in the US market, interested companies can reach out at USAccelerator@abhi.org.uk.
The content above is a summary. For more details, see the source article.
